A Single Group Study to Evaluate the Effects of a Topical Product on Cramps Associated With the Menstrual Cycle

Inclusion Criteria: * Female, aged 18-35. * Has had a regular menstrual cycle for the past six months and is to predict their menstrual cycle and the timing of their menstruation. * Mild to moderate self-reported discomfort during menstruation related to pelvic cramps and back pain. * Generally healthy and not living with any uncontrolled chronic disease. * Has a menstrual cycle between 21 and 35 days in length. * Willing to maintain current diet, sleep, and activity level for the duration of the study. * Resides in the United States. Exclusion Criteria: * Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Current use of any blood thinning medication. * Anyone with known severe allergic reactions. * Anyone with any allergies requiring the use of an Epi-Pen. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Anyone who is pregnant, breastfeeding, or trying to conceive currently or at any point until the end of the study period. * Anyone unwilling to follow the study protocol. * Anyone taking prescription medications for acute or chronic pain. * Anyone with a diagnosis of a condition relating to the menstrual cycle or reproductive system-e.g., polycystic ovary syndrome (PCOS), premenstrual dysphoric disorder (PMDD), endometriosis, etc. * Anyone diagnosed with other conditions that may cause lower back, abdominal, or pelvic discomfort- e.g., fibromyalgia, Crohn's, IBS, UC, chronic constipation, frequent UTIs, bacterial vaginosis (BV), or history or kidney stones. * Anyone who has changed their birth control in the past three months. * Anyone who has had any surgeries or invasive treatments in the past six months or has any planned up until the end of the study period. * Anyone with any major illness in the past three months. * Anyone currently experiencing symptoms associated with perimenopause. * Anyone taking part in any other clinical trials or studies during this study's duration. * Anyone with a history of substance abuse. * Anyone who is currently a smoker or has been in the past three months.